Dosage Forms

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

As the fires of the American opioid crisis continue to burn, can new painkillers step in?

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.

EsoCap CEO Isabelle Racamier tells the story behind a new drug delivery technology that could supplant syrups and pills for illnesses of the esophagus

We talk to a young excipient expert who won The Journal of Pharmaceutical Sciences’ 2021 Outstanding Early Career Scientists award.

A partnership between Gilead Sciences and Georgia State University has tested a new oral antiviral for COVID-19.

On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines.